Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.
July 24, 2017 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that a federal jury delivered a unanimous verdict in favor of Amphastar in a...
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
June 01, 2017 16:05 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President, will be presenting at the Jefferies Global...
Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference
May 10, 2017 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 20th Annual Bank of...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017
May 08, 2017 16:05 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March 31,...
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2017
May 04, 2017 12:13 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2017 ended March 31,...
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on May 8, 2017
May 04, 2017 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2017 ended March 31,...
Amphastar Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
March 31, 2017 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., March 31, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 16th Annual...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016
March 13, 2017 16:21 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months and fiscal year...
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 13, 2017
March 09, 2017 16:01 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2016 ended...
Amphastar Announces the Receipt of a CRL for Intranasal Naloxone for the Emergency Treatment of Opioid Overdose
February 21, 2017 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced today that the U.S. Food and Drug Administration (“FDA”) issued a Complete...